BEAM:NASDAQ
Beam Therapeutics Inc
၂၀.၉၀ US$
arrow_downward
-၀.၁၉%(-၀.၀၄၀) 1D
၂၁.၆၆ US$
arrow_upward
+၃.၆၅% (+၀.၇၆)bedtimeAfter hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
၂၀.၆၀ US$
High
၂၂.၁၀ US$
Low
၂၀.၅၄ US$
Mkt. cap
၂၁၆.၃၁ ဋေ
Avg. vol.
၂.၁၆ သန်း
Volume
၃.၈၉ သန်း
52-wk high
၃၈.၂၆ US$
52-wk low
၂၀.၃၉ US$
EPS
-၁.၀၀ US$
Beta
၂.၂၃
Shares outstanding
၁၀.၃၅ ကုဋေ
No. of employees
၅၅၇
Open
၂၀.၆၀ US$
High
၂၂.၁၀ US$
Low
၂၀.၅၄ US$
Mkt. cap
၂၁၆.၃၁ ဋေ
Avg. vol.
၂.၁၆ သန်း
Volume
၃.၈၉ သန်း
52-wk high
၃၈.၂၆ US$
52-wk low
၂၀.၃၉ US$
EPS
-၁.၀၀ US$
Beta
၂.၂၃
Shares outstanding
၁၀.၃၅ ကုဋေ
No. of employees
၅၅၇
News stories
From web sources and news partners
The Motley Fool
·
ပြီးခဲ့သည့် ၃ နာရီ
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
TradingKey
·
ပြီးခဲ့သည့် ၇ နာရီ
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
JournalArta
·
ပြီးခဲ့သည့် ၃၄ မိနစ်
S&P 500 Falls as AI Spending Fears Weigh on Stocks
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc